US drugmaker AbbVie reported strong first-quarter 2026 results Wednesday, beating market expectations on both sales and ...

UK pharma major GSK reported a solid start to 2026, with first-quarter turnover rising 5% at constant exchange rates to £7.63 ...

The US unit of Israel’s Teva Pharmaceutical Industries and Chicago, USA-based Emalex Biosciences today announced a definitive ...

Family-controlled Italian drugmaker Chiesi Group, and KalVista Pharmaceuticals today announced that the companies have ...

US biotech Biogen delivered a stronger-than-expected first quarter on Wednesday, with both revenue and earnings surpassing ...

US pharma giant Pfizer yesterday announced that it has entered into settlement agreements with generic drug manufacturers - ...

The US Center for Drug Evaluation and Research (CDER) has proposed that Amgen's Tavneos (avacopan) be withdrawn from the ...

An Expert View from Philip Breesch, executive vice president of the CARE Franchise, Chiesi Group. Last year, the neonatal ...

Chinese biopharma Hutchmed today announcesdthat the New Drug Application (NDA) for sovleplenib for the treatment of adult ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance recommending UCB’s Rystiggo ...

British pharma major AstraZeneca (LSE: AZN) reported first-quarter 2026 revenue of $15.3 billion, up 13%, with earnings per ...

US pharma major AbbVie (NYSE: ABBV) has submitted a supplemental application to the US regulator seeking approval of Rinvoq ...